Your browser doesn't support javascript.
loading
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer.
Sunakawa, Yu; Yang, Dongyun; Moran, Miriana; Astrow, Stephanie H; Tsuji, Akihito; Stephens, Craig; Zhang, Wu; Cao, Shu; Takahashi, Takehiro; Denda, Tadamichi; Shimada, Ken; Kochi, Mitsugu; Nakamura, Masato; Kotaka, Masahito; Segawa, Yoshihiko; Masuishi, Toshiki; Takeuchi, Masahiro; Fujii, Masashi; Nakajima, Toshifusa; Ichikawa, Wataru; Lenz, Heinz-Josef.
Afiliación
  • Sunakawa Y; a Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California , Los Angeles , CA , USA.
  • Yang D; b Division of Medical Oncology, Department of Internal Medicine, Showa University Northern Yokohama Hospital , Yokohama , Kanagawa , Japan.
  • Moran M; c Department of Preventive Medicine , Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California , Los Angeles , CA , USA.
  • Astrow SH; d Response Genetics, Inc. , Los Angeles , CA , USA.
  • Tsuji A; d Response Genetics, Inc. , Los Angeles , CA , USA.
  • Stephens C; e Department of Clinical Oncology , Kagawa University Faculty of Medicine Cancer Center, Kagawa University Hospital , Kita-gun , Kagawa , Japan.
  • Zhang W; d Response Genetics, Inc. , Los Angeles , CA , USA.
  • Cao S; a Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California , Los Angeles , CA , USA.
  • Takahashi T; c Department of Preventive Medicine , Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California , Los Angeles , CA , USA.
  • Denda T; f Division of Medical Oncology, Showa University Hospital , Shinagawa-ku, Tokyo , Japan.
  • Shimada K; g Division of Gastroenterology, Chiba Cancer Center , Chuo-ku, Chiba , Japan.
  • Kochi M; h Division of Medical Oncology, Department of Internal Medicine, Showa University Koto Hospital , Toyosu, Koto-ku, Tokyo , Japan.
  • Nakamura M; i Department of Digestive Surgery , Nihon University School of Medicine , Itabashi-ku, Tokyo , Japan.
  • Kotaka M; j Aizawa Comprehensive Cancer Center, Aizawa Hospital , Matsumoto , Nagano , Japan.
  • Segawa Y; k Gastrointestinal Center, Sano Hospital , Kobe , Hyogo , Japan.
  • Masuishi T; l Division of Medical Oncology, Saitama Medical University International Medical Center , Hidaka , Saitama , Japan.
  • Takeuchi M; m Division of Gastroenterology, Tsuchiura Kyodo General Hospital , Tsuchiura , Ibaraki , Japan.
  • Fujii M; n Department of Clinical Medicine (Biostatistics) , Kitasato University School of Pharmacy , Shirokane, Minato-ku, Tokyo , Japan.
  • Nakajima T; i Department of Digestive Surgery , Nihon University School of Medicine , Itabashi-ku, Tokyo , Japan.
  • Ichikawa W; o Japan Clinical Cancer Research Organization , Chuo-ku, Tokyo , Japan.
  • Lenz HJ; p Division of Medical Oncology, Showa University Fujigaoka Hospital , Yokohama , Kanagawa , Japan.
Cancer Biol Ther ; 17(7): 751-9, 2016 07 02.
Article en En | MEDLINE | ID: mdl-27104867

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Cetuximab / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Cetuximab / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos